Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs American Financial Group Inc (AFG) Price & Performance

AbCellera Biologics IncTrade
American Financial Group IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs American Financial Group Inc — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while American Financial Group Inc trades at $144.65 (market cap $11.97B). The key difference: American Financial Group Inc is far larger — about 4× AbCellera Biologics Inc's market cap, and American Financial Group Inc pays a 2.44% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLAFG
Market Cap
$2.99B$11.97B
Sector
HealthFinancials
52-Week High
$9.76$148.71
52-Week Low
$2.78$124.18
Enterprise Value
$2.58B$12.35B
Dividend Yield
2.44%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About American Financial Group Inc

American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.

Read more on AFG